Jpmorgan Chase & CO Codex Dna, Inc. Transaction History

Jpmorgan Chase & CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	23 Added 4.51%	533 $0
Q4 2023 Dec 26, 2024	BUY	N/A	510 New	510 $0
Q4 2022 Feb 13, 2023	SELL	$1.12 - $1.69 $1,450 - $2,188	-1,295 Reduced 71.75%	510 $1,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $906 - $1,257	533 Added 41.9%	1,805 $3,000
Q2 2022 Aug 11, 2022	SELL	$1.8 - $6.45 $11,662 - $41,789	-6,479 Reduced 83.59%	1,272 $2,000
Q1 2022 May 11, 2022	BUY	$4.12 - $10.36 $9,051 - $22,760	2,197 Added 39.56%	7,751 $42,000
Q4 2021 Feb 10, 2022	BUY	$6.31 - $11.96 $16,305 - $30,904	2,584 Added 87.0%	5,554 $60,000
Q3 2021 Nov 12, 2021	BUY	$10.15 - $19.88 $30,145 - $59,043	2,970 New	2,970 $33,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.